Trends in the Aggressiveness of End-of-Life Care for Advanced Stomach Cancer Patients
2
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Purpose It is important to balance the appropriateness of active cancer treatments and endof-life care to improve the quality of life for terminally ill cancer patients. This study describes the treatment patterns and end-of-life care in terminal gastric cancer patients. Materials and Methods We retrospectively analyzed the records of 137 patients with advanced gastric cancer receiving chemotherapy and dying between June 1, 2006 and May 31, 2011. We recorded interval between last chemotherapy dose and death; frequency of emergency room visits or admission to the intensive care unit in the last month before death; rate of hospice referral and agreement with written do-not-resuscitate orders;and change in laboratory values in the last three months before death. Results During the last six months of life, 130 patients (94.9%) received palliative chemotherapy;86 (62.7%) during the final two months; 41 (29.9%) during the final month. During the final month, 53 patients (38.7%) visited an emergency room more than once; 21 (15.3%) were admitted to the intensive care unit. Hospice referral occurred in 54% (74 patients) of the patients; 93.4% (128 patients) gave written do-not-resuscitate orders. Platelets, aspartate aminotransferase and creatinine changed significantly two weeks before death; total bilirubin, one month before; and C-reactive protein, between four and two weeks before death. Conclusion Our results demonstrated that a significant proportion of gastric cancer patients received palliative chemotherapy to the end of life and the patients who stopped the chemotherapy at least one month before death had a lower rate of intensive care unit admission and longer overall survival than those who sustained aggressive chemotherapy until the last months of their lives.
Abstract
Purpose It is important to balance the appropriateness of active cancer treatments and endof-life care to improve the quality of life for terminally ill cancer patients. This study describes the treatment patterns and end-of-life care in terminal gastric cancer patients. Materials and Methods We retrospectively analyzed the records of 137 patients with advanced gastric cancer receiving chemotherapy and dying between June 1, 2006 and May 31, 2011. We recorded interval between last chemotherapy dose and death; frequency of emergency room visits or admission to the intensive care unit in the last month before death; rate of hospice referral and agreement with written do-not-resuscitate orders;and change in laboratory values in the last three months before death. Results During the last six months of life, 130 patients (94.9%) received palliative chemotherapy;86 (62.7%) during the final two months; 41 (29.9%) during the final month. During the final month, 53 patients (38.7%) visited an emergency room more than once; 21 (15.3%) were admitted to the intensive care unit. Hospice referral occurred in 54% (74 patients) of the patients; 93.4% (128 patients) gave written do-not-resuscitate orders. Platelets, aspartate aminotransferase and creatinine changed significantly two weeks before death; total bilirubin, one month before; and C-reactive protein, between four and two weeks before death. Conclusion Our results demonstrated that a significant proportion of gastric cancer patients received palliative chemotherapy to the end of life and the patients who stopped the chemotherapy at least one month before death had a lower rate of intensive care unit admission and longer overall survival than those who sustained aggressive chemotherapy until the last months of their lives.
참고문헌 (16)
- Ho TH, Barbera L, "Trends in the aggressiveness of end-of-life cancer care in the universal health care system of Ontario, Canada", J Clin Oncol, 29, pp.1587~1591 (2011)
- "Cancer pain relief and palliative care. Report of a WHO Expert Committee", World Health Organ Tech Rep Ser, 804, pp.1~75 (1990)
- Earle CC, "Identifying potential indicators of the quality of end-of-life cancer care from administrative data", J Clin Oncol, 21, pp.1133~1138 (2003)
- Gagnon B, "Pattern of care at the end of life: does age make a difference in what happens to women with breast cancer", J Clin Oncol, 22, pp.3458~3465 (2004)
- Keam B, "Aggressiveness of cancer-care near the end-of-life in Korea", Jpn J Clin Oncol, 38, pp.381~386 (2008)
- Braga S, "The aggressiveness of cancer care in the last three months of life: a retrospective single centre analysis", Psychooncology, 16, pp.863~868 (2007)
- Koizumi W, "S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial", Lancet Oncol, 9, pp.215~221 (2008)
- Kamangar F, "Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world", J Clin Oncol, 24, pp.2137~2150 (2006)
- Lunney JR, "Patterns of functional decline at the end of life", JAMA, 289, pp.2387~2392 (2003)
- Emanuel EJ, "Chemotherapy use among Medicare beneficiaries at the end of life", Ann Intern Med, 138, pp.639~643 (2003)
- Kao S, "Use of chemotherapy at end of life in oncology patients", Ann Oncol, 20, pp.1555~1559 (2009)
- Earle CC, "Trends in the aggressiveness of cancer care near the end of life", J Clin Oncol, 22, pp.315~321 (2004)
- Andreis F, "Chemotherapy use at the end of life: a retrospective single centre experience analysis", Tumori, 97, pp.30~34 (2011)
- Ngo-Metzger Q, "Older Asian Americans and Pacific Islanders dying of cancer use hospice less frequently than older white patient", Am J Med, 115, pp.47~53 (2003)
- Matsuyama R, "Why do patients choose chemotherapy near the end of life? A review of the perspective of those facing death from cancer", J Clin Oncol, 24, pp.3490~3496 (2006)
- Glare P, "A systematic review of physicians' survival predictions in terminally ill cancer patients", BMJ, 327, pp.195~198 (2003)